trial · primary record
Patritumab deruxtecan
Breast Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1000 |
| Primary completion | 2033-07-14 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT07060807 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:36.913Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07060807
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.